BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9085089)

  • 1. Antioxidative effect of prostaglandin E2 in thioacetamide-induced liver cirrhosis.
    Buko V; Lukivskaya O; Nikitin V; Kuryan A; Dargel R
    Exp Toxicol Pathol; 1997 Feb; 49(1-2):141-6. PubMed ID: 9085089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in fatty acid composition of plasma, liver microsomes, and erythrocytes in liver cirrhosis induced by oral intake of thioacetamide in rats.
    Moreira E; Fontana L; Periago JL; Sanchéz De Medina F; Gil A
    Hepatology; 1995 Jan; 21(1):199-206. PubMed ID: 7806155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of liver cirrhosis in rats by curcumin.
    Bruck R; Ashkenazi M; Weiss S; Goldiner I; Shapiro H; Aeed H; Genina O; Helpern Z; Pines M
    Liver Int; 2007 Apr; 27(3):373-83. PubMed ID: 17355460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid peroxidation in thioacetamide-induced macronodular rat liver cirrhosis.
    Müller D; Sommer M; Kretzschmar M; Zimmermann T; Buko VU; Lukivskaya O; Dargel R
    Arch Toxicol; 1991; 65(3):199-203. PubMed ID: 2053847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population of hepatic macrophages and response of perfused liver to platelet-activating factor during production of thioacetamide-induced cirrhosis in rats.
    Noda S; Masumi S; Moriyama M; Kannan Y; Ohta M; Sugano T; Yamate J
    Hepatology; 1996 Aug; 24(2):412-8. PubMed ID: 8690413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of thioacetamide-induced liver cirrhosis by the Ras antagonist, farnesylthiosalicylic acid.
    Reif S; Aeed H; Shilo Y; Reich R; Kloog Y; Kweon YO; Bruck R
    J Hepatol; 2004 Aug; 41(2):235-41. PubMed ID: 15288472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ameliorative effect of grape seed proanthocyanidin extract on thioacetamide-induced mouse hepatic fibrosis.
    Li J; Li J; Li S; He B; Mi Y; Cao H; Zhang C; Li L
    Toxicol Lett; 2012 Sep; 213(3):353-60. PubMed ID: 22863721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A protective effect of pyrrolidine dithiocarbamate in a rat model of liver cirrhosis.
    Bruck R; Schey R; Aeed H; Hochman A; Genina O; Pines M
    Liver Int; 2004 Apr; 24(2):169-76. PubMed ID: 15078482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of parenchymal cells from normal and cirrhotic rat liver.
    Zimmermann T; Franke H; Dargel R
    Cell Biochem Funct; 1987 Jan; 5(1):47-54. PubMed ID: 3815745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations to hepatic microcirculation in thioacetamide-induced cirrhotic livers of rats.
    Nakata M; Nakamura K; Koda Y; Kaminou T; Ogami M; Yamada R
    Osaka City Med J; 2002 Jun; 48(1):1-8. PubMed ID: 12375692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of parenchymal cells from experimentally induced macronodular rat liver cirrhosis.
    Müller D; Franke H; Zimmermann T; Dargel R
    Cell Biochem Funct; 1989 Apr; 7(2):119-28. PubMed ID: 2548754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of erythrocytes to lipid peroxidation in cirrhotic rats.
    Oztezcan S; Balkan J; Dogru-Abbasoglu S; Cevikbas U; Aykaç-Toker G; Uysal M
    Arch Med Res; 2005; 36(5):459-63. PubMed ID: 16099321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zonal differences in lipoprotein formation in the thioacetamide-induced micronodular-cirrhotic rat liver.
    Franke H; Potratz I; Dargel R
    Exp Toxicol Pathol; 1994 Dec; 46(6):503-11. PubMed ID: 7703683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A traditional formula, Chunggan extract, attenuates thioacetamide-induced hepatofibrosis via GSH system in rats.
    Kwak KG; Wang JH; Shin JW; Lee DS; Son CG
    Hum Exp Toxicol; 2011 Sep; 30(9):1322-32. PubMed ID: 21071552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antifibrogenic effect of etanercept on development of liver cirrhosis induced by thioacetamide in rats.
    Abdul-Hamid M; Ahmed RR; Moustafa N; Nady R
    Ultrastruct Pathol; 2017; 41(1):23-35. PubMed ID: 27982723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatoprotective and antioxidant activity of Phaseolus trilobus, Ait on bile duct ligation induced liver fibrosis in rats.
    Fursule RA; Patil SD
    J Ethnopharmacol; 2010 Jun; 129(3):416-9. PubMed ID: 20430092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats.
    Shimizu I; Ma YR; Mizobuchi Y; Liu F; Miura T; Nakai Y; Yasuda M; Shiba M; Horie T; Amagaya S; Kawada N; Hori H; Ito S
    Hepatology; 1999 Jan; 29(1):149-60. PubMed ID: 9862861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretion and elimination of insulin by the in vitro perfused pancreas and liver of rats with thioacetamide-induced liver cirrhosis.
    Brömme HJ; Zimmermann T; Blech W
    Horm Metab Res; 1991 Jun; 23(6):262-5. PubMed ID: 1916635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of carnosine against thioacetamide-induced liver cirrhosis in rat.
    Aydin AF; Küskü-Kiraz Z; Doğru-Abbasoğlu S; Güllüoğlu M; Uysal M; Koçak-Toker N
    Peptides; 2010 Jan; 31(1):67-71. PubMed ID: 19958806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PGE2 alleviates kidney and liver damage, decreases plasma renin activity and acute phase response in cirrhotic rats with acute liver damage.
    Rincón-Sánchez AR; Covarrubias A; Rivas-Estilla AM; Pedraza-Chaverrí J; Cruz C; Islas-Carbajal MC; Panduro A; Estanes A; Armendáriz-Borunda J
    Exp Toxicol Pathol; 2005 Mar; 56(4-5):291-303. PubMed ID: 15816358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.